vs

Side-by-side financial comparison of INSTEEL INDUSTRIES INC (IIIN) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.

PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $159.9M, roughly 1.0× INSTEEL INDUSTRIES INC). INSTEEL INDUSTRIES INC runs the higher net margin — 4.7% vs -82.0%, a 86.7% gap on every dollar of revenue. On growth, INSTEEL INDUSTRIES INC posted the faster year-over-year revenue change (23.3% vs -22.7%). INSTEEL INDUSTRIES INC produced more free cash flow last quarter ($-2.2M vs $-36.6M). Over the past eight quarters, INSTEEL INDUSTRIES INC's revenue compounded faster (12.0% CAGR vs -11.5%).

Insteel Industries Inc is a leading U.S. manufacturer of steel reinforcing products including welded wire reinforcement and steel fibers. It primarily serves non-residential construction, infrastructure, and precast concrete segments across North America, delivering high-performance reinforcement solutions for various construction projects.

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

IIIN vs PTCT — Head-to-Head

Bigger by revenue
PTCT
PTCT
1.0× larger
PTCT
$164.7M
$159.9M
IIIN
Growing faster (revenue YoY)
IIIN
IIIN
+46.0% gap
IIIN
23.3%
-22.7%
PTCT
Higher net margin
IIIN
IIIN
86.7% more per $
IIIN
4.7%
-82.0%
PTCT
More free cash flow
IIIN
IIIN
$34.5M more FCF
IIIN
$-2.2M
$-36.6M
PTCT
Faster 2-yr revenue CAGR
IIIN
IIIN
Annualised
IIIN
12.0%
-11.5%
PTCT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
IIIN
IIIN
PTCT
PTCT
Revenue
$159.9M
$164.7M
Net Profit
$7.6M
$-135.0M
Gross Margin
11.3%
Operating Margin
6.0%
-43.3%
Net Margin
4.7%
-82.0%
Revenue YoY
23.3%
-22.7%
Net Profit YoY
602.4%
-104.8%
EPS (diluted)
$0.39
$-1.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IIIN
IIIN
PTCT
PTCT
Q4 25
$159.9M
$164.7M
Q3 25
$177.4M
$211.0M
Q2 25
$179.9M
$178.9M
Q1 25
$160.7M
$1.2B
Q4 24
$129.7M
$213.2M
Q3 24
$134.3M
$196.8M
Q2 24
$145.8M
$186.7M
Q1 24
$127.4M
$210.1M
Net Profit
IIIN
IIIN
PTCT
PTCT
Q4 25
$7.6M
$-135.0M
Q3 25
$14.6M
$15.9M
Q2 25
$15.2M
$-64.8M
Q1 25
$10.2M
$866.6M
Q4 24
$1.1M
$-65.9M
Q3 24
$4.7M
$-106.7M
Q2 24
$6.6M
$-99.2M
Q1 24
$6.9M
$-91.6M
Gross Margin
IIIN
IIIN
PTCT
PTCT
Q4 25
11.3%
Q3 25
16.1%
Q2 25
17.1%
Q1 25
15.3%
Q4 24
7.3%
Q3 24
9.1%
Q2 24
10.6%
Q1 24
12.3%
Operating Margin
IIIN
IIIN
PTCT
PTCT
Q4 25
6.0%
-43.3%
Q3 25
10.8%
1.4%
Q2 25
11.0%
-19.5%
Q1 25
8.3%
82.5%
Q4 24
1.1%
-76.2%
Q3 24
4.5%
-27.7%
Q2 24
6.0%
-21.5%
Q1 24
7.0%
-21.6%
Net Margin
IIIN
IIIN
PTCT
PTCT
Q4 25
4.7%
-82.0%
Q3 25
8.2%
7.5%
Q2 25
8.4%
-36.3%
Q1 25
6.4%
73.7%
Q4 24
0.8%
-30.9%
Q3 24
3.5%
-54.2%
Q2 24
4.5%
-53.1%
Q1 24
5.4%
-43.6%
EPS (diluted)
IIIN
IIIN
PTCT
PTCT
Q4 25
$0.39
$-1.63
Q3 25
$0.74
$0.20
Q2 25
$0.78
$-0.83
Q1 25
$0.52
$10.04
Q4 24
$0.06
$-0.85
Q3 24
$0.24
$-1.39
Q2 24
$0.34
$-1.29
Q1 24
$0.35
$-1.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IIIN
IIIN
PTCT
PTCT
Cash + ST InvestmentsLiquidity on hand
$15.6M
$1.9B
Total DebtLower is stronger
Stockholders' EquityBook value
$358.8M
$-205.3M
Total Assets
$456.1M
$2.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IIIN
IIIN
PTCT
PTCT
Q4 25
$15.6M
$1.9B
Q3 25
$38.6M
$1.7B
Q2 25
$53.7M
$2.0B
Q1 25
$28.4M
$2.0B
Q4 24
$36.0M
$1.1B
Q3 24
$111.5M
$1.0B
Q2 24
$97.7M
$1.1B
Q1 24
$83.9M
$884.8M
Stockholders' Equity
IIIN
IIIN
PTCT
PTCT
Q4 25
$358.8M
$-205.3M
Q3 25
$371.5M
$-155.8M
Q2 25
$356.2M
$-206.5M
Q1 25
$341.4M
$-185.8M
Q4 24
$331.6M
$-1.1B
Q3 24
$350.9M
$-1.1B
Q2 24
$346.0M
$-980.2M
Q1 24
$340.6M
$-893.9M
Total Assets
IIIN
IIIN
PTCT
PTCT
Q4 25
$456.1M
$2.9B
Q3 25
$462.6M
$2.6B
Q2 25
$471.9M
$2.6B
Q1 25
$421.9M
$2.7B
Q4 24
$404.7M
$1.7B
Q3 24
$422.6M
$1.8B
Q2 24
$414.6M
$1.9B
Q1 24
$397.2M
$1.8B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IIIN
IIIN
PTCT
PTCT
Operating Cash FlowLast quarter
$-701.0K
$-34.3M
Free Cash FlowOCF − Capex
$-2.2M
$-36.6M
FCF MarginFCF / Revenue
-1.4%
-22.3%
Capex IntensityCapex / Revenue
0.9%
1.4%
Cash ConversionOCF / Net Profit
-0.09×
TTM Free Cash FlowTrailing 4 quarters
$439.0K
$702.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IIIN
IIIN
PTCT
PTCT
Q4 25
$-701.0K
$-34.3M
Q3 25
$-17.0M
$-66.3M
Q2 25
$28.5M
$-58.3M
Q1 25
$-3.3M
$870.1M
Q4 24
$19.0M
$-30.0M
Q3 24
$16.2M
$-77.0M
Q2 24
$18.8M
$-71.5M
Q1 24
$1.4M
$70.8M
Free Cash Flow
IIIN
IIIN
PTCT
PTCT
Q4 25
$-2.2M
$-36.6M
Q3 25
$-18.7M
$-69.7M
Q2 25
$26.9M
$-59.6M
Q1 25
$-5.5M
$868.4M
Q4 24
$16.3M
$-33.8M
Q3 24
$14.5M
$-77.5M
Q2 24
$15.5M
$-78.8M
Q1 24
$-580.0K
$61.2M
FCF Margin
IIIN
IIIN
PTCT
PTCT
Q4 25
-1.4%
-22.3%
Q3 25
-10.6%
-33.1%
Q2 25
15.0%
-33.3%
Q1 25
-3.5%
73.8%
Q4 24
12.6%
-15.8%
Q3 24
10.8%
-39.4%
Q2 24
10.7%
-42.2%
Q1 24
-0.5%
29.1%
Capex Intensity
IIIN
IIIN
PTCT
PTCT
Q4 25
0.9%
1.4%
Q3 25
1.0%
1.6%
Q2 25
0.9%
0.7%
Q1 25
1.4%
0.1%
Q4 24
2.1%
1.8%
Q3 24
1.3%
0.3%
Q2 24
2.2%
4.0%
Q1 24
1.5%
4.6%
Cash Conversion
IIIN
IIIN
PTCT
PTCT
Q4 25
-0.09×
Q3 25
-1.17×
-4.17×
Q2 25
1.88×
Q1 25
-0.32×
1.00×
Q4 24
17.56×
Q3 24
3.48×
Q2 24
2.86×
Q1 24
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IIIN
IIIN

Welded Wire Reinforcement$108.4M68%
PC Strand$51.6M32%

PTCT
PTCT

Segment breakdown not available.

Related Comparisons